En español In English Contact Us
 
 
 
 
 

Primary Immune Deficiency

The Accredo immune deficiency program specializes in delivering safe, comprehensive immune globulin (IG) therapy in the home.

Accredo is one of the largest providers of home IG therapy in the United States. We manage over 5,000 patients each month, with diagnoses ranging from immune disorders to neurology disorders.
We’re a provider of all available IG brands and administration methods for customized care.
Accredo pharmacists and nurses are extremely knowledgeable and experienced in IG therapies.

Accredo dispenses the following IG drug therapies:
  • Actimmune®
  • Bivigam™
  • Carimune® NF 3, 6, 9, 12%
  • CytoGam®
  • Flebogamma® 5%
  • GamaSTAN®
  • Gammagard® Liquid 10%
  • Gammagard® S/D 5, 10%
  • Gammaked®
  • Gamunex® 10%
  • Hizentra™
  • HyperRHO® S/D
  • HyQvia
  • Immune globulin intravenous (IGIV,IVIG)
  • Immune globulin subcutaneous (seeVivaglobin®)
  • MICRhoGAM®
  • Octagam®
  • Privigen®
  • RhoGAM®
  • Rhophylac®
  • WinRho® SDF

Do you have additional questions regarding IG therapy?
Please call Accredo IVIG at 866.820.4844.

What are immunoglobulins? 
Immunoglobulins are proteins in the blood that help fight off harmful bacteria, viruses, and other invaders. IG products are derived from the plasma of a large number of individuals who have developed antibodies to various microorganisms. All donors and their plasma go through rigorous screenings to be sure their blood is safe to use.

IG products became commercially available in the early 1980s. Six indications have been approved by the U.S. Food and Drug Administration (FDA).

Patients receiving IG therapy for primary immune deficiencies usually receive the therapy for life, whereas those who have neuromuscular disorders receive it intermittently over a period of months, or sometimes years.

Some conditions treated with IG are:

Primary immune deficiencies

  • Common variable immunodeficiency (CVID)
  • Hypogammaglobulinemia
  • Severe combined immunodeficiency (SCID)
  • Wiskott-Aldrich syndrome (WAS)
  • X-linked agammaglobulinemia (XLA) (congenital agammaglobulinemia)

Autoimmune neuromuscular disorders

  • Multifocal Motor Neuropathy (MMN)
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)

All rights in the product names of all third-party products listed on this website, whether or not appearing with the trademark symbol, belong exclusively to their respective owners.

 

Share this page

CloseClose